Local ablative therapy of oligoprogressive disease prolongs disease control by tyrosine kinase inhibitors in oncogene-addicted non–small-cell lung cancer AJ Weickhardt, B Scheier, JM Burke, G Gan, X Lu, PA Bunn Jr, DL Aisner, ... Journal of Thoracic Oncology 7 (12), 1807-1814, 2012 | 684 | 2012 |
Unexplored therapeutic opportunities in the human genome TI Oprea, CG Bologa, S Brunak, A Campbell, GN Gan, A Gaulton, ... Nature reviews Drug discovery 17 (5), 317-332, 2018 | 355 | 2018 |
DNA polymerase zeta (pol ζ) in higher eukaryotes GN Gan, JP Wittschieben, BØ Wittschieben, RD Wood Cell research 18 (1), 174-183, 2008 | 258 | 2008 |
Early clinical outcome with concurrent chemotherapy and extended-field, intensity-modulated radiotherapy for cervical cancer S Beriwal, GN Gan, DE Heron, RN Selvaraj, H Kim, R Lalonde, JL Kelley, ... International Journal of Radiation Oncology* Biology* Physics 68 (1), 166-171, 2007 | 196 | 2007 |
Stereotactic radiation therapy can safely and durably control sites of extra-central nervous system oligoprogressive disease in anaplastic lymphoma kinase-positive lung cancer … GN Gan, AJ Weickhardt, B Scheier, RC Doebele, LE Gaspar, ... International Journal of Radiation Oncology* Biology* Physics 88 (4), 892-898, 2014 | 195 | 2014 |
Effects of conditional overexpression of spermidine/spermine N 1-acetyltransferase on polyamine pool dynamics, cell growth, and sensitivity to polyamine analogs S Vujcic, M Halmekytö, P Diegelman, G Gan, DL Kramer, J Jänne, ... Journal of Biological Chemistry 275 (49), 38319-38328, 2000 | 141 | 2000 |
XactMice: humanizing mouse bone marrow enables microenvironment reconstitution in a patient-derived xenograft model of head and neck cancer JJ Morton, G Bird, SB Keysar, DP Astling, TR Lyons, RT Anderson, ... Oncogene 35 (3), 290-300, 2016 | 133 | 2016 |
Hedgehog signaling alters reliance on EGF receptor signaling and mediates anti-EGFR therapeutic resistance in head and neck cancer SB Keysar, PN Le, RT Anderson, JJ Morton, DW Bowles, JJ Paylor, ... Cancer research 73 (11), 3381-3392, 2013 | 104 | 2013 |
Pediatric CNS tumors N Gupta, A Banerjee, D Haas-Kogan Springer Science & Business Media, 2010 | 75 | 2010 |
Hedgehog signaling drives radioresistance and stroma-driven tumor repopulation in head and neck squamous cancers GN Gan, J Eagles, SB Keysar, G Wang, MJ Glogowska, C Altunbas, ... Cancer research 74 (23), 7024-7036, 2014 | 71 | 2014 |
Inhibition of MK2 suppresses IL‐1β, IL‐6, and TNF‐α‐dependent colorectal cancer growth AL Ray, KL Berggren, S Restrepo Cruz, GN Gan, EJ Beswick International journal of cancer 142 (8), 1702-1711, 2018 | 67 | 2018 |
Evaluation of safety of stereotactic body radiotherapy for the treatment of patients with multiple metastases: findings from the NRG-BR001 phase 1 trial S Chmura, KA Winter, C Robinson, TM Pisansky, V Borges, H Al-Hallaq, ... JAMA oncology 7 (6), 845-852, 2021 | 62 | 2021 |
A phase I and pharmacokinetic study of SAM486A, a novel polyamine biosynthesis inhibitor, administered on a daily-times-five every-three-week schedule in patients with Advanced … LL Siu, EK Rowinsky, LA Hammond, GR Weiss, M Hidalgo, GM Clark, ... Clinical cancer research 8 (7), 2157-2166, 2002 | 54 | 2002 |
Daily diary study of hope, stigma, and functioning in lung cancer patients. LE Steffen, KE Vowles, BW Smith, GN Gan, MJ Edelman Health Psychology 37 (3), 218, 2018 | 37 | 2018 |
Recent advances in targetable therapeutics in metastatic non-squamous NSCLC P Bansal, D Osman, GN Gan, GR Simon, Y Boumber Frontiers in oncology 6, 195170, 2016 | 35 | 2016 |
The dual pathway inhibitor rigosertib is effective in direct patient tumor xenografts of head and neck squamous cell carcinomas RT Anderson, SB Keysar, DW Bowles, MJ Glogowska, DP Astling, ... Molecular cancer therapeutics 12 (10), 1994-2005, 2013 | 35 | 2013 |
Recent advances in immunotherapy in metastatic NSCLC P Bansal, D Osman, GN Gan, GR Simon, Y Boumber Frontiers in oncology 6, 220253, 2016 | 32 | 2016 |
Emerging from their burrow: Hedgehog pathway inhibitors for cancer GN Gan, A Jimeno Expert opinion on investigational drugs 25 (10), 1153-1166, 2016 | 31 | 2016 |
Phase I trial of stereotactic body radiation therapy (SBRT) to multiple metastatic sites: a NRG oncology study SJ Chmura, K Winter, JK Salama, CG Robinson, TM Pisansky, V Borges, ... International Journal of Radiation Oncology, Biology, Physics 102 (3), S68-S69, 2018 | 30 | 2018 |
Stereotactic body radiotherapy as primary therapy for head and neck cancer in the elderly or patients with poor performance A Amini, JD McDermott, G Gan, S Bhatia, W Sumner, CM Fisher, A Jimeno, ... Frontiers in Oncology 4, 274, 2014 | 29 | 2014 |